Jan Apelqvist, MD, PhD

Born 1954

Present position
Senior consultant. Department of Endocrinology, University Hospital of Malmö, Sweden
Associate professor Division for Clinical Sciences, University of Lund, Sweden

Academic education
1973-1979 Medical student, University of Umeå, Sweden
1979 MD (graduated) University of Umeå Sweden
1985 Specialist Internal Medicine, University of Lund
1990 PhD University of Lund, Sweden “Diabetic Foot Ulcer: the importance of  clinical characteristics and prognostic factors for outcome”
1995 Associate Professor Division for Clinical Sciences University of Lund

Clinical position
1980-1981 Resident Regional Hospital of Gällivare
1982-1989 Specialist doctor / Lecturer Department of Internal Medicine University Hospital of Lund
1990-1999 Senor consultant/Senior Lecturer/Assoc Prof Division for Diabetes / Endocrinology, University Hospital of Lund
2000 Senior consultant / Assoc Prof, Department of Endocrinology University Hospital of Malmö
2001-2003 Co Director Department of Endocrinology, University Hospital of Malmö
2003-2004 Director Department of Endocrinology, University Hospital of Malmö
2000- Director Diabetic Foot Centre at the department of Endocrinology, University Hospital of Malmö

Achievements and positions
1995 Clinical Achievement Award  at the University hospital of Lund “For organisation of and implementation of a multidisciplinary foot care team “
1995-1997 Chairman of the Swedish Wound Healing Society
1997-1999 Co chair of the Swedish Wound healing Society
1997-2003 Co chair International Diabetic Foot Study group (DFSG) within EASD 1997-2003 Co chair Steering committee for the international consensus group of the diabetic Foot (endorsed by WHO, ADA, EASD, IDF)
1998 Peccoraro Scientific Award (American Diabetes Association; ADA)-“ for outstanding clinical research in  the diabetic foot”
1997-1998 Chair Consensus group and working committee for the Diabetic Foot Swedish Medical Research Board
1999 Diabetic Foot Award, “Excellent scientific contribution and pre-eminent role in advanced care for diabetic patients with foot problems” at 3rd International Symposium on the diabetic foot, The Netherlands
1999 International Editorial board of the Diabetic Foot, UK
2000 Editorial advisory panel, J of Wound Care, UK
2000-2006 Editorial  board  J Treatments in Endocrinology, USA 
2001 Expert committee ”Diabetic foot wound classification”, American Diabetes Association, (ADA) USA
2001-2002 Working group ETRS (European Tissue Repair Society), Important aspects on wound healing
2001 International Working Group – European Wound Management Association
2002-2004 Steering committee “Computerized Interactive Education system for wound Management” in The Region of Southern Sweden
2003 Advisory to the board of University Hospital of Malmö, “Wound Management”
2004 Novo Nordisk Scientific Award, Sweden 
2003-2004 Working Group, European Wound  Healing Association (EWMA)
2003-2005 Advisory board, Board for devices in Wound Care in The Southern Region of Sweden – “Dressings and topical treatments in Wounds"
2003-2007 Co Chair The international Working Group for the Diabetic Foot ( Task force of the IDF –International Diabetes federation )”
1999-2007 Editorial Board/Steering Group EURODIALAE –EC project
2000-2008 Faculty member, International Postgraduate Course Wound Management
2005-2006 Coordinator Projects –”Process oriented (reward) driven care” University Hospital of Malmö
2006 Advisory Board Wound Management in Southern Region of Sweden
2007 Expert committee for the division of Social welfare of Sweden “National  Evidence based Management programme for Diabetes”
2008 Working/consensus groups WUWHS (World Union Wound Healing Society)

Clinical experience
Specialist in Internal medicine with focus on management of diabetes, multiorgan disease and diabetes related complications. Since 1983 key object management and prevention of diabetes related complications of the lower extremity. Director of a multidisciplinary foot-care centre with co-ordinated in- and out-hospital facilities and since 1999 process-oriented responsibility both in and out hospital. The team consists of diabetologist, orthopaedic surgeons (specialised in foot surgery), vascular surgeon, podiatrist, physiotherapist, casting technician, orthotist and diabetes educated nurses, and involves and coordination with a total 16 disciplines acting as a referral unit for severe diabetes related complications (ulcers, infection, ischemia, osteoarthropathy, neuropathy).

Clinical research
Author of a substantial number of scientific papers in the field of the diabetic foot, diabetes related complications and wound management. The centre has been performing clinical research (7 PhD-thesis published/presented and five ongoing PhD-students) regarding epidemiological studies, risk factors, prognostic factors, outcome and costs of diabetic foot especially foot ulcer and amputation. The team has received international and national recognition for their research and their results has been used in a substantial number of consensus documents Dr Apelqvist has participated, designed and co-ordinated clinical trials in the field of diabetes, peripheral vascular disease wound management since 1983 and is frequently involved in design and evaluation of  clinical  trials. Since 1990 involved in studies regarding health economics and resource utilisation with regard to wound management.

Senior lecturer
Author of and co-author in textbooks, reviews, systematic reviews state of the art articles) as well as internet based education materials. Frequent lecturer who have been giving more than 500 lectures within and without Scandinavia since 1985. Teacher and faculty member in courses in the basic education and training of students (medical students, nurses podiatrist, technicians etc.) as well as on post graduate level.

Administration / organisation of care
Vast experience in organisation of care within and between disciplines. Organised and implemented multidisciplinary teams at two university hospitals with different populations and settings. As well as experience of being acting director for clinics at university level. Involved in projects regarding process or result oriented and care as well as implementation of evidence based medicine since 1995. Frequently involved as an advisory or member of advisory boards, working groups, consensus groups both on national and international level.

Original scientific publications
1. Apelqvist J, Castenfors J, Larsson J, Stenström A, Agardh C-D. Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care 1989; 12: 373-378.
2. Apelqvist J, Castenfors J, Stenström A, Agardh C-D: Wound classification is more important that site of ulceration in the outcome of diabetic foot ulcers. Diabetic Medicine 1989; 6: 526-30.
3. Apelqvist J, Larsson J, Agardh C-D, Stenström A. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabetic Complic 1990; 4: 21-25.
4. Apelqvist J, Larsson J, Agardh C-D: The importance of peripheral pulses, peripheral oedema and local pain for the outcome of diabetic foot ulcers. Diabetic Med 1990; 7: 590-594.
5. Apelqvist J. Diabetic foot ulcers - The importance of clinical characteristics and prognostic factors for the outcome. Thesis University of Lund, Sweden, 1990.
6. Apelqvist J, Castenfors J, Larsson J, Stenström A, Persson G. Ketanserin in the treatment of diabetic foot ulcer with severe peripheral vascular disease. Int Angiology 1990; 9: 120-124.
7. Apelqvist J, Larsson J, Stenström A. Topical treatment of necrotic foot ulcers in diabetic patients. A comparative trial of DuoDerm and Mezinc. Br J Dermatology 1990; 123:787-792.
8. Apelqvist J, Larsson J, Stenström A. Cadexomer iodine gel in the treatment of deep diabetic foot ulcers. In Advances in Wound Management. Ed Harding K.G., Leaper D.L., Turner T.D. MacMillan Magazines Ltd 1992;18:43-55.
9. Apelqvist J, Agardh C-D. The association between clinical factors and outcome of diabetic foot ulcers. Diabetes Res Clin Pract 1992;18:43-55.
10. Apelqvist J, Larsson J, Agardh C-D. Medical risk factors in diabetic patients with foot ulcers and severe peripheral vascular disease and their influence on outcome. J Diabetic Compl 1992;6:167-174.
11. Apelqvist J, Larsson J, Agardh C-D. Long term prognosis for diabetic patients with foot ulcers. J Int Med 1993;233:485-91.
12. Larsson J, Apelqvist J, Castenfors J, Agardh C-D, Stenström A. Distal blood pressure as a predictor for the level of amputation in diabetic patients with foot ulcer. Foot and Ankle 1993;5:247-253.
13. Apelqvist J, Larsson J. Amputation på nedre extremiteten vid diabetes med kartläggning av amputationer i Kopparbergs och Värmlands län. I amputationsfrekvens vid diabetes. Larsson Y Cred. Socialstyrelsen 1993;13-12:7-35. (in Swedish)
14. Falkenberg M, Apelqvist J, Rosenqvist U, Lithner F. Förebyggande åtgärder minskar antalet amputationer för diabetiker. Läkartidningen 1993;47:4221-24.(in Swedish)
15. Apelqvist J, Ragnarsson, Tenvall G, Persson U, Larsson J. Diabetic foot ulcers in a   multidisciplinary setting - an economic analysis of primary healing and healing with amputation. J. Int. Med. 1994;235:463-71.
16. Larsson J, Agardh CD, Apelqvist J, Stenström A. Local signs and symptoms in relation to final amputation level in diabetic patients. Acta Orth. Scand. 1994;65(4):387-393.
17. Lithner F, Apelqvist J. Preventive foot care can decrease major amputations in diabetic patients. Int. J. Diab. Dev. Countries 1994;14:48-51.
18. Apelqvist J. Cost and effect design in clinical trials for pharmaceuticals in ulcer treatment. In cost-effectiveness of wound treatments. Eds Gottrup F, Harding K. Transfer Cambridge, UK. 1994; pp 3:1-14.
19. Apelqvist J, Larsson J, Ragnarsson-Tennvall G, Persson U. Topical treatment of diabetic foot ulcers - an economic analysis of different treatment strategies. Diab. Med. 1995:12:123-128.
20. Larsson J, Agardh CD, Apelqvist J, Stenström A. Clinical characteristics as predictors in the outcome with regard to final amputation level in diabetic patients with foot ulcer. Foot and ankle. 1995 vol 16 No. 2 69-74.
21. Apelqvist J, Larsson J, Ragnarsson-Tennvall G, Persson U. Long term costs in diabetic patients with foot ulcers. Foot and ankle. 1995 vol 16, 388-394.
22. Larsson J, Apelqvist J. Towards less amputations in diabetic patients: Incidence, causes, cost, treatment and prevention. Acta Ort Scand. 1995;12:56-65.
23. Larsson J, Apelqvist J, Agardh CD, Stenström A. Decreasing incidence of major amputations in diabetic patients - a concequence of a multidisciplinary approach? Diab. Med. 1995;12:770-776.
24. Hjelm K, Isacsson Å, Apelqvist J, Sundquist J and Nyberg P. Foreign- and Swedish-born diabetic patients - a population-based study of prevalence, glycamic control and social position. Scand J Soc Med 1996;24 No. 4.
25. Apelqvist J, Torffvit O, Agardh C-D. The effect of the non-ionic contrast medium Iohexol on glomerular and tubular function in diabetic patients. Diabetic Medicine 1996;13:487-492.
26. Apelqvist J, Ragnarsson-Tennvall G. Cavity foot ulcers in diabetic patients - a comparative study of cadexomer ointment and standard treatment. An economic analysis alongside a clinical trial. Acta Derm Ven 1996;76:213-216.
27. Eneroth M, Apelqvist J, Troäng T, Persson B. Operations, total hospial stay and costs of critical leg ischemia. A population-based longitudinal outcome study of 321 patients. Acta Ort Scand, 1996;67 (5):459-465.
28. Hjelm K, Isaksson Å, Apelqvist J, Sundqvist J, Nyberg P. Foreign and Swedish born diabetic patients - a population based study of prevalence, glycemic control and social position - a population based study. Scand. J. Social Medicine 1996;24:243-252.
29. Eneroth M, Apelqvist J, Larsson J, Persson B. Improved wound healing in transtibial amputees receiving supplementary nutrition. Int Orthopedics 1997;21:104-108.
30. Ragnarsson-Tennvall G, Apelqvist J, Cost-effective management of diabetic foot ulcers. PharmacoEconomics. 1997;12:42-53.
31. Hjelm K, Apelqvist J, Nyberg P, Sundqvist J, Isaksson Å. Health, health care utilisation and living conditions in foreign and Swedish born diabetic patients. In Southern Sweden. J. Int. Med. 1997;242:131-141.
32. Eneroth M., Apelqvist J. Clinical characteristics and outcome in diabetic patients with deep foot infections. Foot and Ankle. 1997;18:716-722.
33. Nilsson L., Apelqvist J., Edvinsson L. Effects of alfa-trinositol on peripheral circulation in critical ischemia in diabetic patients with critical ischemia - a pilot study using laser, Doppler-fluxmetry, transcutaneous and dynamic capillaryscopy. Eur Journ Vasc Endovasc Surg 1998, 15; 331-336.
34. Larsson J., Agardh C.D., Apelqvist J., Stenström A. Long term prognosis after amputation in diabetic patients. Clinical Orthopedics and Related Research. 1998, 350; 149-158.
35. Resch S., Apelqvist J., Stenström A., Åström I. Dynamic plantar pressure measurement in 49 diabetic patients diabetic with neuropathy with or without foot ulcers. Foot Ankle Surg 1997:3; 165-174.
36. Apelqvist J. Wound healing in diabetes. Outcome and costs. In healing the diabetic foot wound. Harkless L, Lavery L eds. Clinics in podiatric medicine and surgery. 1998;15:21-39.
37. Eneroth M., Apelqvist J., Larsson J., Persson B. Improved wound healing in transtibial amputees receiving supplementary nutrition. Int Orthopedics 1997;21:104-108.
38. Ragnarsson-Tennvall G, Apelqvist J, Cost-effective management of diabetic foot ulcers. PharmacoEconomics. 1997;12:42-53.
39. Hjelm K., Apelqvist J., Nyberg P., Sundqvist J., Isaksson Å. Health, care utilisation and living conditions in foreign and Swedish born diabetic patients. In Southern Sweden. J. Int. Med. 1997;242:131-141.
40. Eneroth M., Apelqvist J. Clinical characteristics and outcome in diabetic patients with deep foot infections. Foot and Ankle. 1997;18:716-722.
41. Larsson J., Agardh C.D., Apelqvist J., Stenström A. Long term prognosis after amputation in diabetic patients. Clinical Orthopedics and Related Research. 1998, 350; 149-158.
42. Apelqvist J. Wound healing in diabetes. Outcome and costs. In healing the diabetic foot wound. Harkless L, Lavery L eds. Clinics in podiatric medicine and surgery. 1998;15:21-39.
43. Hjelm K., Apelqvist J., Isaksson Å. Health care professional’s perceptions of beliefs about health and illness in immigrants in diabetes mellitus. Practical Diab Int 1998;15:23-7.
44. Ragnarson Tennvall G., Apeqlvist J. The economic cost of the diabetic foot I: Fagila E, Giuffrida G, Oriani G (eds). The ischemic diabetic foot. Milano Editrice Kurtis, 1999:185-192.
45. Hjelm K., Apelqvist J., Nyberg P., Isaksson Å. Beliefs about health and illness essential for self-care practice – a comparison of migrant Yugoslavian and Swedish diabetic females. Journal of Advanced Nursing 1999, 30, 1147-1159.
46. Persson U., Willis, M., Ödegaard K., Apelqvist J. The Cost-Effectiveness of Treating Diabetic Lower Exremity Ulcers with Becaplermin (Regranex). A care model with an application using Swedish cost data. Value in Health 2000:3 (suppl 1)39-46.
47. Eneroth M., Larsson J., Apelqvist J. Foot infections in diabetes mellitus – entity with different characteristics, treatment and prognosis. Journal Diabetic Complications 2000; 13 (5-6):254-263.
48. Ragnarsson-Tennvall G, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmaco Economics 2000:18;222-238.
49. Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcer. J Diab and it’s Compl. 2000:14:235-241.
50. Ragnarson Tennvall G, Apelqvist J, Eneroth M. The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations. J Int. Med. 2000;248:397-405.
51. Hjelm K, Nyberg P, Apelqvist J. Chronic lower leg ulcers in Sweden: a survey of wound management. J Wound Care 2000;3:133-138.
52. Apelqvist J, Larsson J. What is the Most Effective Way to Reduce Incidence of Amputation in the Diab/Metab Res Rev 2000:16 (Suppl 1):75-83.
53. Ragnarson Tennvall G, Apelqvist J. Prevention of diabetes related foot ulcers and amputation. A cost effectiveness analysis with Markov-model simulations. Diabetologia. 2001 44:2077-2087.
54. Hjelm K., Apelqvist J. Self-monitoring of blood glucose: frequency determinants and self adjustment of treatment in adult Swedish diabetic population. Practical Diabetes Int. 2001 18;157-63.
55. Norlund A., Apelqvist J., Nyberg P., Bitzén P-O, Schersten B. Costs of illness of adult diabetes mellitus underestimated if co-morbidity is not considered. J Int. Med. 2001 250:57-65.
56. Hjelm K., Sundqvist J., Apelqvist J. The influence of socio-economic status and life-style on selfreported health in diabetics and non-diabetics – a comparison of foreign-born and Swedish-born individuals. Primary Health Care Research and Development 2002;3:181-191.
57. Hjelm K., Nyberg P., Apelqvist J. Determinants of ambulatory care in a  defined adult Swedish diabetic population. Diab. Res. Clin. Practice 2002;56:49-61.
58. Hjelm K., Apelqvist J., Nyberg P., Gender influences beliefs about health and illness in diabetic subjects with severe foot lesions. Journal of Advanced Nursing 2002;40:1-13.
59. Hjelm K., Nyberg P., Apelqvist J.: The influence of belifs about health and illness on footcare in diabetic subjects with a severe footlesiens:A comparison of foreign – and swedish – born individuals. Clinical Effectiveness in nursing 2003;7(1),1-14.
60. Kalani M., Brismar K., Apelqvist J., Eliasson B., Eriksson J., Fagrell B., Jörneskog B. Effect of Daltiperin on healing of chronic foot ulcers in diabetic patients with pheripheral arterial occlusive disease – prospective, randomized, double blind and placebo controlled study. Diabetes Care 2003;6:2575-2580.
61. Hjelm K., Bard K., Nyberg P., Apelqvist J.: Religious and cultural distances in
believes about health and illness in women with diabetes mellitus of different origin living in Sweden. International Journal of nursing studies 2003;40:627-643.
62. Hjelm K., Rolfe M., Bryar R., Andersson B-L, Fletcher M. Comparison of the
Management of patients with chronic leg ulcers by nurses working in  the  community Sweden and UK. J Wound Care 2003;12(3)93-98.
63. Eneroth M., Larsson J., Apelqvist J., Edmonds M.E., Foster A., Gough A., Reike H., Salomon M. The challenge of multicenter studies in diabetic patients with foot infection. The Foot 2004:13 (7).
66. Lohman M., Thomsen J.K., Edmonds M.E., Harding K.G., Gottrup F., Apelqvist J. Safety and performance of a new non-adhesive foam dressing for the treatment of diabetic foot ulcers. J Wound Care 2004 :13 (6)118-120.
67. Ragnarsson Tenvall G., Apelqvist J. Health Economic Consequences of Diabetic Foot. Clin. Lesions Infectious Disease 2004 :39 (suppl. 2) 132-139.
68. Malcholm K.R., Bard K., McPhil B., Hjelm K. ,Apelqvist J., Fletcher M., Andersson B.L. International collabaration: to adress common problems in health care, processes practicalities and power. Int Nurs Rev 2004:51 (3); 140-148
69. Nabuurs-Franssen M.H., Redecop W.K., Ragnarsson-Tennvall G., Apelqvist J., Bakker K., Grill-Wikell H., Schaper N.C. Quality of Life in Diabetic Patients: the impact of neuropathy and foot ulcer Diabetologia 2005 48;1906-10.
70. Melhus Å., Apelqvist J., Larsson J., Eneroth M. Levofloxacin – associated akilles tendon rupture and tendinopathy. Scand J Infect Dis 2003; 35:768-770.
71. Eneroth M., Oscarsson C., Larsson J., Apelqvist J. Nutritional supplementation for diabetic foot ulcers: the first RCT. J Wound Care 2004:13 (6)250-254.
72. Hjelm K., Bard K., Nyberg P., Apelqvist J. Beliefs about health and diabetes in men of different ethnic origin. J Advanced nursing. 2005: 50 (1); 47-59.
73. Hjelm K., Bard K., Nyberg P., Apelqvist J. Swedish and Middle-Eastern born Women's beliefs about gestational Diabetes. Midwifery 2005: 21 (1) 44-60.
74. Annersten M., Frid A., Dahlberg G., Högberg M., Apelqvist J. Structured Diabetes education in Sweden. A national Inquiry involving 583 nurses working with diabetes patients in hospitals and primary care facilities. Practical Diabetes International 2006 23 138-141.
75. Löndahl M., Katzman P., Nilsson A., Hammarlund C., Hugo-Persson M., Apelqvist J. Design of the hyperbaric therapy in diabetics with chronic foot ulcer study (HODFU) J Wound Care 2006.
76. Prompers L., Huijberts M., Apelqvist J. et al. High prevalence of ischemia, infection and serious co-morbitity in patients with diabetic foot disease in Europe. Baseline results from the EURODIALE study. Diabetologia  2007 50(1) 18-25.
77. Boulton A.J.M., Vileikyte L., Ragnarson-Tennvall G., Apelqvist J. The Global Burden of the Diabetic Foot Disease. Lancet 2005 12: 1719-24 77.
78. Prompers L., Huijberts M., Apelqvist J. et al. Optimal organisation of health care in diabetic foot disease: introduction to the EURODIALE study Between guidelines and clinical practise; J Lower Extremity Wounds. 2007 6(1) 11-7.
79. Hjelm K., Bard K., Nyberg P., Apelqvist J. Management of Gestational Diabetes from the patients perspective – a comparison of Swedish and Middle Eastern Born Woman. J Clin Nurs 2007 16(1) 168-78.
80. Kalani M., Apelqvist J., Blombeck M., Eliason B., Eriksson J.W., Hamstein A., Jörneskog G. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. Thrombosis Research. 2007 120 85 653-61.
81. Hjelm K., Bard K., Nyberg P., Apelqvist J. Management of gestational diabetes from patient's perspective – a comparison of Swedish and Middle-Estern born women. Journal of Clinical Nursing 2007;16(1):168-178.
82. Jude E., Apelqvist J., Spraul M., Martini J. and the Silver Dressing Group. Prospective Randomized Controlled Study of Non-ischemic Diabetic Foot Ulcer Dressed with Hydrofiber Containing Ionic Silver or Calcium Alginate Dressing. Diab Med 2007, 24, 280–288.
83. Hjelm K., Berntorp K., Fridh A., Nyberg P., Apelqvist J. Beliefs about health and illness different in woman managed for gestational diabetes in two organisations. Midwifery 2007 12: 8-28.
84. Prompers L., Huijbert M., Apelqvist J. et al. Prediction of outcome in individuals with diabetes and foot ulcers: focus on the difference between individuals with and without peripheral artery disease. The EURODIALE-study. Diabetologia 2008  51 (5) 747-55.
85. Magnus Löndahl, Per Katzman, Olle Fredholm, Anders Nilsson, Jan Apelqvist The chronic Diabetic foot ulcer is a sign of systemic cardiovascular disease. J Wound Care 2008 17(1) 12-16.
86. Glans F., Elgzyri T., Shaat N., Lindholm E., Apelquist J., Groop L. Immigrants from the Middle-East have a more severe form of type 2 diabetes than Swedish-born patients. Diabetic Medicine 2008 25 (3) 303-307.
87. Hjelm K., Bard K., Berntorp K., Apelqvist J. Beliefs about health and illness postpartum in women born in Sweden and the Middle East. Midwifery 2008 Jan 16.
88. Flack S., Apelqvist J., Trueman P., Keith M., Williams D., Sheehan P. An economic evaluation of vacuum assisted closure compared to traditional and advanced wound dressings in the treatment of diabetic foot ulcers. J Wound Care 2008 17(2) 71-8.
89. Apelqvist J. The foot in perspective” Diab Met Res Rev 2008 24, In Press.
90. Larsson J., Eneroth M., Apelqvist J., Stenström A. Sustained decrease of major amputation in diabetic patients - An analysis of a 20–year period in a defined population (628 amputations in 461 patients). Acta Orth Scand 2008 In press.
91. Mandl T., Granberg V., Apelqvist J., Wollmer P., Manthorpe R., Jacobsson L.T.H. Autonomic nervous symptoms in primary Sjögren's syndrome. Rheumatology. 2008 In Press (April).
92. Apelqvist J., Armstrong D.G., Lavery L.A., Boulton A.J. Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds. Am J Surgery 2008. In Press (May).
93. Mandl T., Granberg V., Apelqvist J., Wollmer P., Manthorpe R., Jacobsson L.T.H. Assessment of autonomic nervous symptoms - The Swedish version of the Autonomic Symptom Profile (ASP). 2008 Accepted.
94. Prompers L., Huijberts M., Apelqvist J., Jude E., Piaggesi A., Bakker K., Edmonds M., Holstein P., Jirkovska A., Mauricio D., Ragnarson Tennvall G., Reike H., Spraul M., Uccioli L.,  Urbancic V., Van Acker K., Van Baal J., Van Merode F., Schaper N. Delivery of care to diabetic foot ulcer patients in daily practice: Results of the Eurodiale study. Submitted.
95. Hjelm K., Löndahl M., Katzman., Apelqvist J. Diabetic persons with foot ulcers and their perceptions of hyperbaric oxygen chamber therapy. Submitted.
96. Johansson A., Ljung Å., Apelqvist J. Open prospective study on the topical treatment of inter digital fungal infections in diabetic patients. Submitted.
97. Bengtsson L., Jonsson M., Apelqvist J. Wound related Pain underestimated  in Patients with Diabetes and Foot Ulcer. Submitted 2008.
98. Hjelm K., Nyberg P., Apelqvist J. GDM – Beliefs in women born in Africa and Sweden Health/illness beliefs and migrants. Submitted.
99. Prompers L., Huijberts M., Schaper N., Apelqvist J., Bakker K., Edmonds M., Holstein P., Jude E., Jirkovska A., Mauricio D., Piaggesi A., Reike H., Spraul M., Van Acker K., Van Baal S., Van Merode F., Uccioli L., Urbancic V. and G. Ragnarson Tennvall.  Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the EURODIALE study. Submitted.
100. Miao Jonasson J., Ye W., Sprén P., Apelqvist J., Nyrén O., Brismar K. Risk of lower extremity amputation in patients with type 1 diabetes – a population-based cohort study in Sweden. Submitted Diab Care 2008.
101. Owings T.M. , Apelqvist J., Stenström A., Becker M., Bus S., Kalpen A., Ulbrecht J.S., Cavanagh P. Plantar Pressures in Diabetic Foot Ulcer Patients who have Remained Healed. Submitted.
102. Torffvit O., Apelqvist J., Brismar K., Eliasson B., Eriksson J., Kalani M., Jörneskog G. The Effect of low molecular weight heparin dalteparin on renal function in diabetic patients with chronic neuro-ischemic foot ulcers. Submitted.
103. Schumann H., Apelqvist J., Schmidtchen A., Hansson C. An open, non-comparative, multi-centre investigation exploring the tolerability and performance of an absorbent soft silicone foam dressing containing silver in the treatment of chronic wounds. Submitted.
104. Elgzyri T., Ekberg G., Pettersson K., Lundell A., Apelqvist J. Arterial doppler Ultrasound, the role in management and decision for the type of vascular interventional diabetic foot. In manuscript.
105. Apelqvist J., Elgzyri T., Eneroth M., Larsson J., Thörne J. Factors related to short term outcome of neuroischemic/ischemic foot ulcer in diabetic patients with and without angioplasty. In manuscript.
Annersten M., Apelqvist J., Eneroth M., Larsson J., Nyberg P., Thörne J. Complexity of factors related to outcome in diabetic foot ulcer. In manuscript.
Apelqvist J., Bitzén P.O., Eneroth M., Larsson J., Nyberg P., Schersten B. Foot ulcer and utilization of preventive foot care in a diabetic population in Southern Sweden. In manuscript.
Apelqvist J., Eneroth M., Larsson J., Nyberg P., Thörne J. Factors related to long term outcome and recurrence of ulcers in diabetic patients with a previously healed foot ulcer. In manuscript.
Annersten M., Frid A., Apelqvist J., Pilhammar Andersson E. Diabetes in Home Nursing Service in a Swedish Municipality. In manuscript.

Other publications (reviews, reports, text books, chapters in text books)
1. Stenström A., Apelquist J., Björnsson H. Behandling av diabetikers fotsår vid speciell medicinsk-ortopedisk mottagning. J Swedish Medical Assoc. 1985;82;4318-4323. (In Swedish).
2. Apelqvist J., Stenström A. Behandling av patienter med diabetessår. Sårvårdsprogram och diaserie för utbildning av läkare och sjukvårdspersonal. Lederle 1985. (In Swedish).
Apelqvist J. Den diabetiska foten. I Sårvårdshandboken (Ed. Arndt I). LIC 1986 pp. 20-24. (In Swedish).
3. Apelqvist J. Utvärdering av fast medicin-konsult vid ortopedkliniken i Lund. Intern rapport 1987. (In Swedish).
4. Apelqvist J. Borgsen G., Dupros I., Hellgren R., Stenström A. Den diabetiska foten - praktiska aspekter på behandling av diabetessår. Videofilm 15 min. Fyra språk-versioner. Distribution Norden. LIC 1987. (In Swedish).
5. Apelqvist J. Metabola aspekter på sårläkning speciellt med avseende på diabetes. Behandling av patienter med diabetesgangrän. I Symposium om behandling av patienter med kroniska sår. Stockholm, Göteborg, Linköping, Uppsala, Gävle, Uddevalla. 1986/1987 Lederle 1987 pp. 12-21. (In Swedish).
6. Apelqvist J. Internmedicinska aspekter på den diabetiska foten. Principer för lokalbehandling av sår. Kan man med ocklusion behandla nekrotiska fotsår hos diabetiker. Temamöte kring ben och fotsår. Malmö. Symposieskrift. Mölnlycke Health Care 1988 pp. 5-8, 13-17. (In Swedish).
7. Apelqvist J., Eckert B. Utvärdering av diabetesjourens nuvarande verksamhet samt alternativ för framtida utformning. Intern rapport 1990. (In Swedish).
8. Apelqvist J., Borgsen G., Dupros I. Behandling av nekrotiska fotsår hos diabetiker. Videofilm 8 min VHS/EUMATIC. Fyra språkversioner. Distr: Mölnlycke Health Care/LIC 1991. (In Swedish).
9. Apelqvist J. Befattningsbeskrivning för diabetessjuksköterska vid medicinska kliniken lasarettet Lund. Intern rapport 1991(In Swedish).
10. Apelqvist J. Fotsår hos diabetiker. I Sår och sårbehandling - klinik och praktik (Ed. Sandberg C). 1992 pp. 9-11. (In Swedish).
11. Apelqvist J. Sår på fötter och underben: Fotsår hos diabetiker. I Sårvårdshandboken (Ed. Arndt I, Fagrell B) LIC Förlag 1992 pp. 26-35. (In Swedish).
12. Apelqvist J., Larsson J., Agardh C.D. Diabetic foot ulcers: The importance of clinical characteristics and prognostic factors for the outcome. In Advances in Wound Management. Ed.: Harding K.G., Leaper D.L., Turner T.D. MacMillan Magazines Limited 1992 pp. 98-100.
13. Apelqvist J., Anehus S. A pilot study of the wound healing properties of LHP cream in patients with diabetic foot ulcers. Internal report 1992.
14. Apelqvist J., Ekberg G., Nilsson A., Nofeldt B., Anehus S.. A comparative trial of lipid stabilized hydrogen peroxide cream and ointment dressing in the treatment of superficial foot ulcers in diabetic patients. Internal report 1993.
15. Apelqvist J., Siösteen K. L-300 ointment in the treatment of diabetic foot ulcers a open non-comparative phase II clinical trial. Clinical trial report 1993.
16. Nikula R., Lundgren P.A. mfl. Prestationsrelaterad ersättning för specialistvård inom MLL. Delprojekt VIK 1994: 2-16. (In Swedish).
17. Torffvit O., Apelqvist J. Diabetes och neuropati. Vårdprogram för diabetes mellitus i Malmöhus läns landsting, Hälso- och sjukvårdsavdeln. 1995. ISBN 91-8585-58-4. (In Swedish).
18. Thörne J., Apelqvist J., Plate G. Kritisk ischemi vid diabetes mellitus. Vårdprogram för diabetes mellitus i Malmöhus läns landsting. Hälso- och sjukvårdsavdeln. 1995. ISBN 91-8585-58-4. (In Swedish).
19. Apelqvist J., Larsson J., Svensson M. Den diabetiska foten. Vårdprogram för diabetes mellitus i Malmöhus läns landsting, Hälso- och sjukvårdsavdeln. 1995. ISBN 91-8585-58-4. (In Swedish).
20. Apelqvist J. Kan amputationsfrekvensen hos diabetiker minskas i enlighet med St. Vincentdeklarationens mål? Diabetesforum 93. 1994 pp. 15-17.
21. Apelqvist J. Sjukvårdspolitiska aspekter på den diabetiska foten. Diabetesforum. Sammanfattningar 1994 pp. 93-94. (In Swedish).
22. Apelqvist J. Vad betyder störd makrocirkulation - betydelsen av ankel- och tåtryck. Diabetesforum 1993. Sammanfattningar 1994 pp. 95-96. (In Swedish).
23. Apelqvist J., Dupros I. På god fot med diabetes. Svenska diabetesförbundets skriftserie 1994;3:3-15. (In Swedish).
24. Larsson J., Apelqvist J. The diabetic foot. (Book rev). Acta Orthop Scand 1994;65:485-7.
25. Apelqvist J., Larsson J. The organization of diabetic foot care. In: Advances in Wound Management. Cherry G.W., Leaper D.J., Lawrence J.C., Milward P. (eds.) Macmillan Magazines Ltd., London 1995 pp. 168-170, ISBN 0 333 650409.
26. Apelqvist J. Fotsår hos diabetiker. Sår. 1995;3:84-91. (In Swedish).
27. Apelquist J., Stenström A. Djupa infektioner i den diabetiska foten. 1995; pp. 5-151, Ljungberg, Södertälje, ISBN 91-86326-83-X. (In Swedish).
28. Apelqvist J., Ragnarsson-Tenvall G., Larsson J., Persson U. Long term cost for foot ulcers in diabetic patients in a multidisciplinary setting. In: Advances in Wound Management. Macmillan Magazines Ltd., London 1996, pp. 209-213.
29. Apelqvist J., Ragnarsson-Tennvall G. Cavity foot ulcers in diabetic patients. A comparative study of cadexomer ointment and standard treatment. In: Advances in Wound Management. Macmillan Magazines Ltd., London 1996, pp. 214-118.
30. Apelqvist J. Den diabetiska foten - state of the art. Socialstyrelsen 1996, pp. 2-19. (In Swedish).
31. Apelqvist J. Den diabetiska foten. I Den diabetiska foten. Hedström S-Å m.fl. (eds.). 1996, pp. 18-44. (In Swedish).
32. Apelqvist J. Foten i centrum. Diabetolog-Nytt 1997 pp. 1-15. (In Swedish).
34. Apelqvist J., Larsson J. Vilka fotproblem uppträder vid diabetes och hur vanliga är dessa? Program/proceedings. Consenuskonferens. Diabetikers fotproblem. Spri 1998, 315;10-36. ISSN nr. 0281-6881. (In Swedish).
35.Apelqvist J. Riskfaktorer för försämrad läkning av fotsår. Program/proceedings Consenuskonferens. Diabetikers fotproblem. Spri 1998. 315; 38-42. ISSN nr 0281-6881.
36. Larsson J. Amputationer: Var när och hur? Program/proceedings. Consenuskonferens. Diabetikers fotproblem. Spri 1998, 315;86 – 93. ISSN nr. 0281-6881. (In Swedish).
37. Apelqvist J. Fotteam - Vad är det och vilka behandlingsresultat har man? 140 - 146. (In Swedish).
38. Jönsson B., Ragnarsson-Tennvall G. Vilka är de samhällsekonomiska konsekvenserna av olika strategier för prevention och behandling? Läkartidningen 1998; 148 - 161. (In Swedish).
39. Apelqvist J. Long-term prognosis and cost in the diabetic foot. In The high risk foot in diabetes mellitus. Frykberg (eds.). Churchill Livingstone 1999.
40. Apelqvist J. Bergqvist D. Diabetesfoten. I Diabetes. Agardh C.D., Berne C., Östman J. (red.). 2:a upplagan. 1999. (In Swedish).
41. Ragnarsson-Tennvall G., Apelqvist J. The economic costs of diabetic foot. In Vascular complications in diabetes mellitus. 1999.
42. Apelqvist J. The diabetic foot. In Textbook of endocrinology. Groop L (eds.) McGraw Hill. 1999.
43. Apelqvist J. Incidence and cost of foot lesions in diabetic patients. In ECHM consensus conference on hypobaric oxygen in the treatment of foot lesions in diabetic patients. Vatell F., Matthieu D. (eds.) 1998, pp. 41-56.
44. Footproblems in diabetes. Consensus statement. – SPRI/MFR 1998, 317. ISSN 0281-6881 (In Swedish).
45. Apelqvist J. Den diabetiska foten – state of the art. Diabetolognytt 1996, 1; 36-41. (In Swedish).
46. Apelqvist J. Diabetesfoten – nu ytterligare ett steg framåt. Diabetolognytt 1998, 3; 15. (In Swedish).
47. Oscarsson, Carina. Förebyggande fotvård spar pengar och lidande. Vårdfacket 1996, 20; 47-48. Carlsson H., et al. Fotsår ska förebyggas - antalet amputationer kan halveras med bättre. (In Swedish).
48. Berg-Wahlstedt A. Diabetesamputationer in Lund har minskat med 80%. PRO Pensionären 1997; 34-36. (In Swedish).
49. Carlsson H. Tusentals amputeras i onödan. Sårbara diabetesfötter måste tas om hand snabbt av multidisciplinära fotvårdsteam. Lund visar vägen. Dagens Medicin del II 1997, 22; 14-15. (In Swedish).
50. Svensson M. et al. Provsmaka äpplets fotkurs på internet. Medicinronden 1998, 6/6;1. (In Swedish).
51. Dupros I., Oscarsson C., et al. Navet i fotteamet. Medicinronden 1998, 6;2-3. (In Swedish).
52. Apelqvist J., Bergqvist D., Eneroth M., Lartsson J. Diabetikers fotproblem – rätt prevention och behandling kan halvera risken för amputation. Läkartidningen (Journ for Swedish Med Ass.), 1999 (In Swedish).
53. Bergqvist D., Apelqvist J., Jörneskog G., Karacagil S., Swedenborg J. Klinisk bedömning av kritisk extremitetsischemi. Läkartidningen (Journ for Swedish Med Ass.), 1999 (In Swedish).
54. Apelqvist J. Fotkomplikationer vid diabetes – ett problem med stor aktualitet. KÄRiLET 1998, 10; 4-7. (In Swedish).
55. Apelqvist J., Eneroth M., Larsson J. Foten – en diabetikers achilleshäl. I Diabetes – genetiskt öde eller välfärdens pris. Forskningens dag 1998. Informationsenheten. Lunds Universitet, 1998, 44-46.
56. Carlsson H., et al. Fibroblaster för behandling av diabetessår på väg till Sverige. Dagens Medicin III, 1999, 12-13.
57. Aspegren C.  Räddning för diabetesfötter. Medicinskt Forum. 1998,7; 16-18.
58. Apelqvist J. Foten i centrum. Diabetolog-Nytt 1997 pp. 1-15.
59. Apelqvist J., Larsson J. Vilka fotproblem uppträder vid diabetes och hur vanliga är dessa? Program/proceedings. Consenuskonferens. Diabetikers fotproblem. Spri 1998, 315;10-36. ISSN nr. 0281-6881.
60. Apelqvist J. Riskfaktorer för försämrad läkning av fotsår. Program/proceedings Consensuskonferens. Diabetikers fotproblem. Spri 1998. 315; 38-42. ISSN nr. 0281-6881.
61. Larsson J. Amputationer: Var när och hur? Program/proceedings. Consensuskonferens. Diabetikers fotproblem. Spri 1998, 315;86 – 93. ISSN nr. 0281-6881.
62. Apelqvist J. Fotteam - Vad är det och vilka behandlingsresultat har man? 140 - 146.
63. Jönsson B., Ragnarsson-Tennvall G. Vilka är de samhällsekonomiska konsekvenserna av olika strategier för prevention och behandling? Läkartidningen 1998; 148 - 161.
64. Apelqvist J. Long-term prognosis and cost in the diabetic foot. In The high risk foot in diabetes mellitus. Frykberg (eds.). Churchill Livingstone.
65. Apelqvist J., Bergqvist D. Diabetesfoten. I Diabetes. Agardh C.D., Berne C., Östman J. (red.) 3:eupplagan. 2005.
66. Ragnarsson-Tennvall G., Apelqvist J. The economic costs of diabetic foot. In Vascular complications in diabetes mellitus. In press 1999.
67. Apelqvist J. The diabetic foot. In Endocrinology and metabolism. Pinchera A. et al. (eds.) MacGrow Hill International London UK 2001;635-640.
68. Apelqvist J. Incidence and cost of foot lesions in diabetic patients. In ECHM consensus conference on hyperbaric oxygen in the treatment of foot lesions in diabetic patients. Vatell F., Matthieu D. (eds.) 1998, pp 41-56.
69. Foot problems in diabetes. Consensus statement. – SPRI/MFR 1998, 317. ISSN 0281-6881.
70. Apelqvist J. Diabetesfoten – nu ytterligare ett steg framåt. Diabetolognytt 1998, 3; 15.
71. Carlsson H., et al. Fotsår ska förebyggas - antalet amputationer kan halveras med bättre diabetesvård. Dagens Medicin 1998: 17:26.
72. Berg-Wahlstedt A. Diabetesamputationer in Lund har minskat med 80%. PRO Pensionären 1997; 34-36.
73. Carlsson H. Tusentals amputeras i onödan .Sårbara diabetesfötter måste tas om hand snabbt av multidisciplinära fotvårdsteam. Lund visar vägen. Dagens Medicin del II 1997, 22; 14-15.
74. Svensson M. et al. Provsmaka äpplets fotkurs på internet. Medicinronden 1998, 6/6;1.
75. Dupros I., Oscarsson C., et al. Navet i fotteamet. Medicinronden 1998, 6;2-3.
76. Apelqvist J., Bergqvist D., Eneroth M., Lartsson J. Diabetikers fotproblem – rätt prevention och behandling kan halvera risken för amputation. Läkartidningen vol 96 nr 1-2. 1999.
77. Bergqvist D., Apelqvist J., Jörneskog G., Karacagil S., Swedenborg J. Klinisk värdering av kritisk ischemi ska alltid göras före amputation. Läkartidningen (Journ for Swedish Med Ass.) 1999, 96;727-729.
78. Apelqvist J. Fotkomplikationer vid diabetes – ett problem med stor aktualitet. KÄRiLET 1998, 10; 4-7. (In Swedish).
79. Apelqvist J., Eneroth M., Larsson J. Foten – en diabetikers achilleshäl. I Diabetes – genetiskt öde eller välfärdens pris. Forskningens dag 1998. Informationsenheten. Lunds universitet, 1998, 44-46. (In Swedish).
80. Carlsson H., et al. Fibroblaster för behandling av diabetessår på väg till Sverige. Dagens Medicin III, 1999, 12-13. (In Swedish).
81. Aspegren C. Räddning för diabetesfötter. Medicinskt Forum. 1998, 7; 16-18. (In Swedish).
82. International Working Group on the Diabetic Foot. International Concensus on the Diabetic Foot, 1999 ISBN 90-9012716-X.
83. International Working Group on the Diabetic Foot. Practical guidelines on the management and the prevention of the diabetic foot, 1999 ISBN 90-9012716-X.
84. Eneroth M. Factors affecting wound healing after major amputation for vascular disease: a review. Prosthetics and Orthotics International 1999, 23,195-208.
85. Apelvist J. The Economic Cost and Quality of Life Issues Associated With the Diabetic Foot: Implications for New Strategies 1999.
86. Ragnarson Tennvall G. m.fl. Det lönar sig att satsa på komplikationsförbyggande åtgärder – ett räkneexempel från diabetesvården. Läkartidningen 1997:94, 2817-2821. (In Swedish).
87. Apelqvist J., Nyberg P., Magnusson H. Resursutnyttjande vid omhändertagande av och behandling av sår i nedre extremiteterna inklusive trycksår i öppen vård. Intern rapport Mölnlycke Heath Care 2001. (In Swedish).
88. Hjelm K. Invandrare, hälsa och diabetes: Jämförelser av utlands- och svenskfödda personer med diabetes boende i Sverige. Integration och folkhälsa. Vision och realitet inför år 2000. Socialmedicinsk tidskrift. 2000; 1:32-41. (In Swedish).
89. Larsson J., Stenström A. Benartärsjukdom – Ortopediska aspekter. Incitament nr 6/99. (In Swedish).
90. Apelqvist J., Bergqvist D., Eneroth M., Larsson J. Rätt prevention och behandling kan halvera risken för amputation. Läkartidn 1999; 96:37-41. (In Swedish).
91. Apelqvist J., Bakker K., van Houtum W.H., Nabuurs-Fransson M.H., Schaper N.C. International consensus and practical guidelines on the management and the prevention of the diabetic foot. Diab. Metabolism Res Rev 2000:16 (suppl. 1) 84-92.
92. Apelqvist J., Clever H., Dreyer U., Färm I., Linglöf T., Strasser A. and Weinhardt K. Randomised comparative study of cutinova versus traditional treatment for the management of neuropathic diabetic foot ulcers. Beiersdorf, Hamburg 2000. Internal rapport.
93. Apelqvist J. Studies that demand both caution and respective. J Wound Care, 2001, 10;353.
94. Apelqvist J. The diabetic Foot: an economic view. The Diabetic Voice 2000; 45:26-28.
95. Apelqvist J. Cost as outcomes. In innovation in wound care. 2001.
96. Phalanga V., Harding K.G. (eds.) Apelqvist J. The role of cadexomer Iodine in Wound Bed Preparation. In the Clinical relevance of wound preparation. Springer Verlag Berlin 2002:29-38.
97. Apelqvist J. The Foot. In hypertension and diabetes. Mogensen C.E. (ed.) Lippingcott, Williams and Wilkins London UK 2003;75-90.
98. Larsson J., Stenström A., Eneroth M., Apelqvist J.: Osteoartropathi – en mindre omtalad komplikation vid diabetes. Medikament 2002. (In Swedish).
99. Ragnarsson-Tennvall G., Apelqvist J.: Health economic consequenses of diabetic foot lesions. Journal of infectious disease. 2004.
100. Apelqvist J., Bergqvist D., Diabetesfoten. Östman J., Berne C., Agard C. (eds.). Diabetes. Studentlitteratur Stockholm 2002;332-344. (In Swedish).
101. Apelqvist J. Fotsår vid diabetes – en multidisciplinär utmaning. Incitament 2002;7 639-645. (In Swedish).
102. Apelqvist J. Diabetesfoten – vårdens akilleshäl. I diabetes i skåne – ett forskningsperspektiv. FoU enheten för forskning och utveckling. Westin J. (ed.) Lund 2003;124-137. (In Swedish).
103. Schaper N.C., Apelqvist J., Bakker K. The international consensus and practical guidelines on the management and prevention of the diabetic foot. Curr Diab Rep 2003 3(6) 475-9.
104. Lipsky et al. International working group on the diabetic foot. Progress report: The diabetic foot ulcer classifications for research purpose 2003. Netherlands.
105. Harding K.G. et al. International working group on the diabetic foot. Progress report: Wound healing and treatment of people with diabetic foot ulcer. Harding K.G. 2003.
106. Schaper et al. International working group on the diabetic foot. Progress report: The diabetic foot ulcer classifications for research purpose 2003. Netherlands. Int Working group on the Diabetic Foot.
107. Apelqvist J., Ragnarsson/Tennvall G. Social and socioeconomic factors in management and prevention of the diabetic foot. In Diabetes and Foot Care. (Eds.) Bakker K., Foster A., van Houtum W.W., Riley P. International Diabetes Federation. Brussels, Belgium info@idf.org  www.idf.org 2005:36-39.
108. Ragnarsson/Tennvall G. Health economics and the diabetic foot. Social and socioeconomic factors in management. In Diabetes and Foot Care. (Eds.) Bakker K., Foster A., van Houtum W.W., Riley P. International Diabetes Federation. Brussels, Belgium info@idf.org  www.idf.org 2005: 40-49.
109. Apelqvist J. Diabetesfoten Internetmedicin.se. www.internetmedicin.se  2005. (In Swedish).
110. Apelqvist J., Bergqvist D., Diabetesfoten. Östman J., Berne C., Agard C. (eds.). Diabetes. 3:e Upplagan, Studentlitteratur Stockholm 2005;340-354. (In Swedish).
111. Ragnarsson Tennvall G., Apelqvist J. Counting the costs of the Diabetic Foot. Diabetes Voice. 2005 50:8-10  www.diabetesvoice.org
112. Apelqvist J. Antibiotikabehandling vid fotinfektioner hos individer med diabetes. 2006 www.Internetmedicin.se  (In Swedish).
113. Apelqvist J. Diabetesfoten – Perifer cirkulation, risk för morbiditet och mortalitet, Incitament 2007 7 541-543 (In Swedish).
114. Apelqvist J., Bakker K., Valk G.D. Diabetic Foot Ulcer – From Fiction to Management. The development of global guidelines. EWMA Journal 2007, 7:31-33.
115. Apelqvist J. Diabetic foot ulcers: Evidence, cost and management. The Diabetic Foot Journal Vol 10 No. 1 2007.
116. Apelqvist J. Diabetic Foot Ulcer – from fiction to management. Diabetic Foot 2007.
117. Jeffcoate W. et. al. Diab Met Res Rev 2008, The effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes – a systematic review. Diabetic Met Res Rev. In Press.
118. Apelqvist J., Bakker K., van Houtum W.H., Schaper N.C. The Development of global consensus guidelines on the management of the diabetic foot. Diabetes/Metabolism, Research and reviews. 2008 24. In Press.